Nonobese diabetic mice and the genetics of diabetes susceptibility

Current Diabetes Reports

Volumn 5, Issue 2, 2005, Pages 141-148

  Leiter, Edward H ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN; PERFORIN; PROSTAGLANDIN E RECEPTOR;

ALLELE; DIABETOGENESIS; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE SEGREGATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME; GENOME ANALYSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INCIDENCE; INHERITANCE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE STRAIN; MUTAGENESIS; NOMENCLATURE; NONHUMAN; PENETRANCE; PHENOTYPE; PROGENY; REVIEW; RISK ASSESSMENT; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE;

EID: 20444481382     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-005-0042-z     Document Type: Review

References (55)

1. Zavattari P, Lampis R, Motzo C, et al.: Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HIA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, -DRB1 disease loci. Hum Mol Genet 2001, 10:881-889.
2. Rich SS, Concannon P: Challenges and strategies for investigating the genetic complexity of common human diseases. Diabetes 2002, 51(suppl 3):S288-S294.
3. Concannon P, Gogolin-Ewens KJ, Hinds DA, et al.: A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998, 19:292-296.
4. Ueda H, Howson JM, Esposito L, et al.: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
5. Ridgway WM: The non obese diabetic (NOD) mouse: a unique model for understanding the interaction between genetics and T cell responses. Rev Endocr Metab Disord 2003, 4:263-269.
6. Choisy-Rossi CM, Holl TM, Pierce MA, et al.: Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience. J Immunol 2004, 173:3791-3800.
7. Serreze DV, Leiter EH: Genes and pathways underlying autoimmune diabetes in NOD mice. In Molecular Pathology of Insulin-Dependent Diabetes Mellitus, vol 4. Edited by von Herrath M. New York: Karger; 2001:31-67.
8. Serreze DV, Holl TM, Marron MP, et al.: MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. J Immunol 2004, 172:871-879.
9. Hamilton-Williams EE, Serreze DV, Charlton B, et al.: Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in NOD mice. Proc Natl Acad Sci U S A 2001, 98:11533-11538.
10. Ikegami H, Makino S: The NOD mouse and its related strains. In Animal Models of Diabetes A Primer. Edited by Sima AAE Shafrir E. Amsterdam: Harwood Academic Publishers; 2001:43-61.
11. Mathews CE, Graser RT, Bagley RJ, et al.: Genetic analysis of resistance to type 1 diabetes in ALR/Lt mice, a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress. Immunogenetics 2003, 55:491-496.
12. Pomerleau DP, Bagley RJ, Holl TM, et al.: MHC-linked diabetes susceptibility in NOD/Lt mice: subcongenic analysis localizes a component of "Idd16" at the H2-D end of the diabetogenic H2g7 complex. Diabetes 2005, in press.
13. Boulard O, Damotte D, N, et al.: An interval tightly linked to but distinct from the H2 complex controls both overt diabetes (Idd16) and chronic experimental autoimmune thyroiditis (Ceat1) in nonobese diabetic mice. Diabetes 2002, 51:2141-2147.
14. Hattori M, Yamato E, Itoh N, et al.: Homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice. J Immunol 1999, 163:1721-1724.
15. Ghosh S, Palmer SM, Rodrigues NR, et al.: Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat Genet 1993, 4:404-409.
16. McAleer MA, Reifsnyder P, Palmer SM, et al.: Crosses of NOD mice with the related NON strain: a polygenic model for type I diabetes. Diabetes 1995, 44:1186-1195.
17. Hill NJ, Lyons PA, Armitage N, et al.: The NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 2000, 49:1744-1747.
18. Wicker LS, Chamberlain G, Hunter K, et al.: Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J Immunol 2004, 173:164-173.
19. Serreze DV, Bridgett MB, Chapman HD, et al.: Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for β2-microglobulin. J Immunol 1998, 160:1472-1478.
20. Fox CJ, Paterson AD, Morrin-Toth SM, et al.: Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis. Am J Hum Genet 2000, 67:67-81.
21. Lord CJ, Bohlander SK, Hopes EA, et al.: Mapping the diabetes polygene Idd3 on mouse chromosome 3 by use of novel congenic strains. Mamm Genome 1995, 6:563-570.
22. Lyons PA, Armitage N, Lord CJ, et al.: Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouse. Diabetes 2001, 50:2633-2637.
23. Lyons PA, Hancock WW, Denny F, et al.: The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 2000, 13:107-115.
24. Siegmund T, Armitage N, Wicker LS, et al.: Analysis of the mouse CD30 gene, a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes 2000, 49:1612-1616.
25. Brodnicki TC, McClive P, Cooper S, et al.: Localization of Idd11 using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene. Immunogenetics 2000, 51:37-41.
26. Rogner UC, Boitard C, Morin J, et al.: Three loci on mouse chromosome 6 influence onset and final incidence of type i diabetes in nod.c3h congenic strains. Genomics 2001, 74:163-171.
27. McDuffie M: Derivation of diabetes-resistant congenic lines from the nonobese diabetic mouse. Clin Immunol 2000, 96:119-130.
28. Kanagawa O, Xu G, Tevaarwerk A, et al.: Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci. J Immunol 2000, 164:3919-3923.
29. Grattan M, Mi QS, Meagher C, et al.: Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 2002, 51:215-223.
30. Bridgett MM, Cetkovic-Cvrlje M, Narayanswami S, et al.: Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta cells. Diabetes 1998, 47:1848-1856.
31. Hall RJ, Hollis-Moffatt JE, Merriman ME, et al.: An autoimmune diabetes locus (Idd21) on mouse chromosome 18. Mamm Genome 2003, 14:335-339.
32. Leiter EH: Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions. Diabetologia 2002, 45:296-308.
33. Wang B, Andre I, Gonzalez A, et al.: Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc Natl Acad Sci U S A 1997, 94:13844-13849.
34. Serreze DV, Post CM, Chapman HD, et al.: Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 2000, 49:2007-2011.
35. Hultgren B, Huang XJ, Dybdal N, et al.: Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 1996, 45:812-817.
36. Kagi D, Odermatt B, Ohashi PS, et al.: Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J Exp Med 1996, 183:2143-2152.
37. Hattori M, Yamato E, Matsumoto E, et al.: Occurrence of pretype I diabetes (pre-IDDM) and type II diabetes (NIDDM) in BC1 [(NOD x Mus spretus)F1 x NOD] mice. In Lessons from Animal Diabetes, vol 6. Edited by Shafrir E. Boston: Birkhaüser; 1996:83-95.
38. Gonzalez A, Katz JD, Benoist C, et al.: Genetic control of diabetes progression. Immunity 1997, 7:873-883.
39. Leiter EH: NOD mice and related strains: origin, husbandry, and biology. In NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer, and Other Diseases. Edited by Leiter EH, Atkinson MA. Medical Intelligence Unit. Austin: R.G. Landes Co.; 1998:1-35.
40. Leiter EH: The role of environmental factors in modulating insulin dependent diabetes. In Current Topics in Immunology and Microbiology. The Role of Microorganisms in Non-infectious Disease. Edited by de Vries R, et al. Berlin: Springer Verlag; 1990:39-55.
41. Leiter E: The NOD mouse: a model for insulin dependent diabetes mellitus. In Current Protocols in Immunology, vol 3. Edited by Coligan JE, et al. New York: John Wiley & Sons; 1997:15.19.11-15.19.23.
42. Encinas JA, Wicker LS, Peterson LB, et al.: QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2. Nat Genet 1999, 21:158-160.
43. Boulard O, Fluteau G, Eloy L, et al.: Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J Immunol 2002, 168:4192-4201.
44. Vyse TJ, Todd JA: Genetic analysis of autoimmune disease. Cell 1996, 85:311-318.
45. Yu S, Medling B, Yagita H, et al.: Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice. J Autoimmun 2001, 16:37-46.
46. Greve B, Vijayakrishnan L, Kubal A, et al.: The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis. J Immunol 2004, 173:157-163.
47. Koarada S, Wu Y, Fertig N, et al.: Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol 2004, 173:2315-2323.
48. Prochazka M, Leiter EH, Serreze DV, et al.: Three recessive loci required for insulin-dependent diabetes in NOD mice. Science 1987, 237:286-289.
49. Mathews CE, Leiter EH, Spirina O, et al.: mt-Nd2 allele of the ALR/Lt mouse confers resistance against both chemically induced and autoimmune diabetes. Diabetologia 2005, in press.
50. Uchigata Y, Okada T, Gong JS, et al.: A mitochondrial genotype associated with the development of autoimmune-related type 1 diabetes. Diabetes Care 2002, 25:2106.
51. De Gouyon B, Melanitou E, Richard MF, et al.: Genetic analysis of diabetes and insulitis in an interspecific cross of the nonobese diabetic mouse with Mus spretus. Proc Natl Acad Sci U S A 1993, 90:1877-1881.
52. Pandarpurkar M, Wilson-Fritch L, Corvera S, et al.: Ian4 is required for mitochondrial integrity and T cell survival. Proc Natl Acad Sci U S A 2003, 100:10382-10387.
53. Yokoi N, Komeda K, Wang HY, et al.: Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet 2002, 31:391-394.
54. Payne F, Smyth DJ, Pask R, et al.: Haplotype tag single nucleotide polymorphism analysis of the human orthologues of the rat type 1 diabetes genes Ian4 (Lyp/Iddm1) and Cblb. Diabetes 2004, 53:505-509.
55. Tian C, Bagley J, Cretin N, et al.: Prevention of type 1 diabetes by gene therapy. J Clin Invest 2004, 114:969-978.